Develop, Partner, Acquire or Avoid: Where is Investment for Digital Pathology Headed?
Published: May 4, 2023
2nd May 2023 – Imogen Fitt – Featured on itnonline.com
The digital pathology market today is rife with potential for investment and returns, potential for major shifts in competitive dynamics, and potential for vendors to have a real impact on the way pathologists work
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest in December, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. There, discussions centered around the progress of the market and its inevitable future developments.
Click here to read the full article.
Share on LinkedInRelated Report
Digital Pathology Market Intelligence Service
Ongoing series of reports delivered over the yearDigital Pathology Market Intelligence Service
This Market Intelligence Service provides a rolling 12-month coverage of the global Digital Pathology market.
Find out more
Related Report
Digital Pathology
Published April 2023Digital Pathology
This is a brochure for Signify Research’s 2023 report on the global market for Digital Pathology published April 2023.
Find out more